18792-00-2 Usage
General Description
2-Bromo-4-cyanothiophene is a chemical compound with the molecular formula C6H3BrNS. It is a derivative of thiophene, a heterocyclic compound containing a sulfur atom in its five-membered ring. 2-Bromo-4-cyanothiophene is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals due to its ability to undergo various chemical reactions, including cross-coupling reactions. It is also used as a building block in the production of organic electronic materials, such as organic light-emitting diodes (OLEDs) and organic photovoltaic cells. The compound is a colorless to light yellow liquid with a distinctive odor, and it is classified as a hazardous material due to its flammability and toxicity.
Check Digit Verification of cas no
The CAS Registry Mumber 18792-00-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,7,9 and 2 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 18792-00:
(7*1)+(6*8)+(5*7)+(4*9)+(3*2)+(2*0)+(1*0)=132
132 % 10 = 2
So 18792-00-2 is a valid CAS Registry Number.
18792-00-2Relevant articles and documents
2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE
-
Page/Page column 228-229, (2021/06/26)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.
